Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activityJustin LaVigne, John M. Streicher, Ryan Hecksel et al.|Scientific Reports|2021Cited by 115
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine preventionJennifer Y. Xie, Frank Porreca, David W. Dodick et al.|Cephalalgia|2017Cited by 86
Analgesic Potential of Terpenes Derived from Cannabis sativaErika Liktor‐Busa, Tally M. Largent‐Milnes, John M. Streicher et al.|Pharmacological Reviews|2021Cited by 70
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.Keith M. Olson, John M. Streicher, Wei Lei et al.|PubMed|2017Cited by 45